Transcend Australia welcomes advice from the National Health and Medical Research Council (NHMRC) that puberty blockers can be considered for trans and gender diverse young people under 18. The advice is open for public consultation until 1 pm AEDT on 18 January 2027. This is advice, and full guidelines are expected in 2028.
For families who have spent years advocating for their children to be heard and supported, we welcome the advice’s focus on what each young person needs. Decisions about puberty suppression should be made by young people, together with their parents or carers and their healthcare team, guided by the available evidence, careful clinical assessment and the young person’s individual circumstances.
The advice says clinicians can consider puberty blockers when a young person wants this care, has started puberty, experiences gender incongruence and is assessed as suitable for treatment. It also makes clear that a young person does not need to be distressed before they can be considered for care.
Queensland families need access to care
In Queensland, a ministerial direction continues to prevent young people under 18 from starting puberty blockers or gender affirming hormones for gender dysphoria in the public health system, if they had not started treatment before 28 January 2025.
The NHMRC’s advice gives the Queensland Government an opportunity to lift the restriction and restore access to clinically appropriate care through specialist public services. Where a young person lives should never determine whether they can access the care they need.
Read Transcend Australia’s full position statement (PDF).

